Rege Nephro Co., Ltd. (Headquarters: Kyoto, Japan; Chief Executive Officer: Akifumi Morinaka) has been selected as a first-term startup for the “Drug Discovery and Practical Application Promotion Program Support Project” promoted by Nakanoshima Qross, a hub for the industrialization of future medicine in Osaka.

This program is recognized under the Ministry of Health, Labour and Welfare’s “Drug Discovery Cluster Campus Development Project” and aims to provide end-to-end support for the practical application of drug discovery seeds held by startups and academic institutions, strengthening Japan’s innovative drug discovery capabilities.

Rege Nephro will leverage the growth support programs and opportunities to connect with overseas ecosystems offered by this initiative to further advance the research, development, and social implementation of innovative drug discovery.

Details on the support program: https://www.nakanoshima-qross.jp/en/news/1773/
Selected companies: https://www.nakanoshima-qross.jp/en/news/2030/

Media Inquiries:
Mariko Iwamura　
Rege Nephro Co., Ltd.
TEL: +81-75-744-6858
E-mail: info@regenephro.co.jp